Updates are available Correction dated 2024-01-11
Click to view Correction: https://doi.org/10.1007/s10719-024-10146-x
-
Authors
Šimunić-Briški, Nina
Dukarić, Vedran
Očić, Mateja
Madžar, Tomislav
Vinicki, Martina
Frkatović-Hodžić, Azra
Knjaz, Damir
Lauc, Gordan
-
Funding
Funding for this research was provided by:
European Structural and Investment Fund, Croatian National Centre of Competence in Molecular Diagnostics (KK.01.2.2.03.0006)
European Structural and Investment Fund, Croatian National Centre of Competence in Molecular Diagnostics (KK.01.2.2.03.0006)
European Structural and Investment Fund, Croatian National Centre of Competence in Molecular Diagnostics (KK.01.2.2.03.0006)
European Structural and Investment Fund, Croatian National Centre of Competence in Molecular Diagnostics (KK.01.2.2.03.0006)
European Structural and Investment Fund, Croatian National Centre of Competence in Molecular Diagnostics (KK.01.2.2.03.0006)
European Structural and Investment Fund, Croatian National Centre of Competence in Molecular Diagnostics (KK.01.2.2.03.0006)
European Structural and Investment Fund, Croatian National Centre of Competence in Molecular Diagnostics (KK.01.2.2.03.0006)
European Structural and Investment Fund, Croatian National Centre of Competence in Molecular Diagnostics (KK.01.2.2.03.0006)
European Research Council ERC-Synergy Grant „GlycanSwitch “ (#101071386)
European Research Council ERC-Synergy Grant „GlycanSwitch “ (#101071386)
European Research Council ERC-Synergy Grant „GlycanSwitch “ (#101071386)
European Research Council ERC-Synergy Grant „GlycanSwitch “ (#101071386)
European Research Council ERC-Synergy Grant „GlycanSwitch “ (#101071386)
European Research Council ERC-Synergy Grant „GlycanSwitch “ (#101071386)
European Research Council ERC-Synergy Grant „GlycanSwitch “ (#101071386)
European Research Council ERC-Synergy Grant „GlycanSwitch “ (#101071386)
- License Information
-
More Information
Article History
Received: 6 December 2023
Revised: 6 December 2023
Accepted: 13 December 2023
First Online: 26 December 2023
Change Date: 11 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10719-024-10146-x
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of the Faculty of Kinesiology, University of Zagreb (31/2017) and Ethics Committee of School of Medicine, University of Zagreb (380-59-10106-18-111/110).
: G. Lauc is the founder and owner of Genos Ltd, a private research organization that specializes in high throughput glycomic analyses and has several patents in this field. N. Šimunić-Briški, M. Vinicki and A. Frkatović-Hodžić are employees of Genos Ltd. G. Lauc is also co-founder of GlycanAge Ltd and is listed as an inventor on patents EP3011335B1 and US9910046B2 that protect the use of GlycanAge® to predict biological age. All other authors declare no conflicts of interest.
